Adequate antibody response to BioNTech COVID vaccine in a multiple sclerosis patient treated with siponimod

Detalles Bibliográficos
Autores principales: Siddiqui, Gulnaz, Maloni, Heidi, Nava, Victor E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669414/
https://www.ncbi.nlm.nih.gov/pubmed/34924749
http://dx.doi.org/10.1186/s41983-021-00428-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669414/
https://www.ncbi.nlm.nih.gov/pubmed/34924749
http://dx.doi.org/10.1186/s41983-021-00428-8

Ejemplares similares